200 related articles for article (PubMed ID: 15965991)
1. Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features.
Kaviani A; Ataie-Fashtami L; Fateh M; Sheikhbahaee N; Ghodsi M; Zand N; Djavid GE
Lasers Surg Med; 2005 Jun; 36(5):377-82. PubMed ID: 15965991
[TBL] [Abstract][Full Text] [Related]
2. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
Gayl Schweitzer V
Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
[TBL] [Abstract][Full Text] [Related]
3. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
4. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
5. Combined CO(2) laser with photodynamic therapy for the treatment of nodular basal cell carcinomas.
Whitaker IS; Shokrollahi K; James W; Mishra A; Lohana P; Murison MC
Ann Plast Surg; 2007 Nov; 59(5):484-8. PubMed ID: 17992139
[TBL] [Abstract][Full Text] [Related]
6. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
7. Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers.
Souza CS; Neves AB; Felício LA; Ferreira J; Kurachi C; Bagnato VS
Dermatol Surg; 2007 Feb; 33(2):194-8. PubMed ID: 17300605
[TBL] [Abstract][Full Text] [Related]
8. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic laser therapy of basal-cell carcinoma of the lid.
Hintschich C; Feyh J; Beyer-Machule C; Riedel K; Ludwig K
Ger J Ophthalmol; 1993 Aug; 2(4-5):212-7. PubMed ID: 8220101
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
12. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Kübler AC; de Carpentier J; Hopper C; Leonard AG; Putnam G
Int J Oral Maxillofac Surg; 2001 Dec; 30(6):504-9. PubMed ID: 11829232
[TBL] [Abstract][Full Text] [Related]
13. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Volgin VN; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2012 Sep; 44(7):533-40. PubMed ID: 22851213
[TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy of nasal basal cell carcinoma].
Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
[TBL] [Abstract][Full Text] [Related]
16. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
Oseroff AR; Blumenson LR; Wilson BD; Mang TS; Bellnier DA; Parsons JC; Frawley N; Cooper M; Zeitouni N; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):417-26. PubMed ID: 16788928
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
19. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.
Mosterd K; Thissen MR; Nelemans P; Kelleners-Smeets NW; Janssen RL; Broekhof KG; Neumann HA; Steijlen PM; Kuijpers DI
Br J Dermatol; 2008 Sep; 159(4):864-70. PubMed ID: 18717680
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas.
Santoro O; Bandieramonte G; Melloni E; Marchesini R; Zunino F; Lepera P; De Palo G
Cancer Res; 1990 Aug; 50(15):4501-3. PubMed ID: 2369729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
